Arkolith/Insider Trading/PRLD/Form 4

Baker Brothers Life Sciences LP

Director, 10% OwnerPrelude Therapeutics Inc (PRLD) · full profile →Form 4 · filed Dec 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 13, 2023Grant(A)593K$3.15$1.9M1.6M
Dec 13, 2023Grant(A)7.3M$3.15$23.1M18.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-058488) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML